(Q66033347)
Statements
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of MVA-BN in a Dose Response Regimen Followed by Administration of Dryvax in Healthy Adult Volunteers (English)
0 references
May 2004
0 references
August 2007
0 references
91
0 references
18 year
0 references
32 year
0 references